Clinical Trial Contract Template for the United States

A Clinical Trial Contract is a comprehensive legal agreement that governs the conduct of human subject research studies in the United States. This contract establishes the legal framework between pharmaceutical sponsors, research institutions, principal investigators, and contract research organizations (CROs) to ensure compliant and ethical clinical trial operations under federal law.

When do you need this document?

You need a Clinical Trial Contract whenever conducting Phase I, II, III, or IV clinical trials involving investigational drugs, medical devices, or biologics in the United States. This includes multi-site studies where pharmaceutical companies sponsor research at academic medical centers, hospitals, or private research facilities. The contract is essential when establishing relationships between drug sponsors and clinical investigators, when outsourcing trial management to CROs, or when conducting post-market surveillance studies. You also need this agreement for bioequivalence studies, vaccine trials, and any research requiring Investigational New Drug (IND) applications or Investigational Device Exemptions (IDE).

Key legal considerations

Your Clinical Trial Contract must address critical regulatory compliance requirements including adherence to Good Clinical Practice (GCP) guidelines, FDA inspection readiness, and proper documentation standards. The agreement should clearly define responsibilities for adverse event reporting, safety monitoring, and protocol deviations. Financial disclosure requirements under 21 CFR Part 54 must be addressed, including investigator conflict of interest declarations and payment structures. Data ownership, intellectual property rights, and publication policies require careful negotiation to protect both sponsor investments and academic freedom. The contract must include robust indemnification clauses, insurance requirements, and liability allocation between parties. HIPAA compliance provisions are essential for protecting patient privacy and ensuring proper data handling throughout the study lifecycle.

Legal requirements in United States

Under United States federal law, your Clinical Trial Contract must ensure compliance with the Food, Drug, and Cosmetic Act (FDCA) and comprehensive FDA regulations governing clinical research. The agreement must address 21 CFR Part 312 requirements for IND applications and investigational drug handling. Informed consent procedures must comply with 21 CFR Part 50, while Institutional Review Board (IRB) oversight must meet 21 CFR Part 56 standards. Electronic records and signatures must conform to 21 CFR Part 11 requirements for data integrity and audit trails. The contract must incorporate state-specific clinical trial regulations, including patient bill of rights provisions and additional informed consent requirements that may vary by jurisdiction. HIPAA authorization and data security measures are mandatory for protecting participant health information. Your agreement must also address FDA inspection protocols, record retention requirements, and procedures for regulatory submissions throughout the trial conduct.